Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2023-01-27 00:00:00 ET · period of report 2023-01-25 · accession 0001209191-23-005234 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-01-27 | 2023-01-25+ | VRTX | Lee Yuchun | Dir | S - Sale+OE | $316.15 | -8,000 | 1,875 | -81% | -$2.53M |
| DM | 2023-01-27 | 2023-01-25+ | VRTX | Lee Yuchun | Dir | M - OptEx | $72.14 | +8,000 | 5,875 | New | +$577.1K |
| DM | 2023-01-27 | 2023-01-25+ | VRTX | Lee Yuchun | Dir | M - OptEx | $0.00 | -8,000 | 5,429 | -60% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-26 | S | D | 302 | $315.42 | 5,573 | D | — | — | (F6) Open market sales reported on this line occurred at a weighted average price of $315.42 (range $315.23 to $315.66). (F2) Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common Stock | 2023-01-26 | S | D | 1,140 | $316.82 | 4,433 | D | — | — | (F2) Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F7) Open market sales reported on this line occurred at a weighted average price of $316.82 (range $316.23 to $317.16). |
| 3 | Common | Common Stock | 2023-01-26 | S | D | 478 | $319.25 | 2,955 | D | — | — | (F9) Open market sales reported on this line occurred at a weighted average price of $319.25 (range $318.79 to $319.56). (F2) Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
| 4 | Common | Common Stock | 2023-01-26 | S | D | 1,000 | $317.95 | 3,433 | D | — | — | (F8) Open market sales reported on this line occurred at a weighted average price of $317.95 (range $317.43 to $318.35). (F2) Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
| 5 | Common | Common Stock | 2023-01-26 | M | A | 4,000 | $72.14 | 5,875 | D | — | — | |
| 6 | Common | Common Stock | 2023-01-25 | S | D | 579 | $314.95 | 1,875 | D | — | — | (F5) Open market sales reported on this line occurred at a weighted average price of $314.95 (range $314.58 to $315.14). (F2) Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
| 7 | Common | Common Stock | 2023-01-25 | S | D | 2,621 | $314.10 | 2,454 | D | — | — | (F2) Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F4) Open market sales reported on this line occurred at a weighted average price of $314.10 (range $313.53 to $314.50). |
| 8 | Common | Common Stock | 2023-01-25 | S | D | 800 | $312.80 | 5,075 | D | — | — | (F3) Open market sales reported on this line occurred at a weighted average price of $312.80 (range $312.41 to $313.06). (F2) Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
| 9 | Common | Common Stock | 2023-01-25 | M | A | 4,000 | $72.14 | 5,875 | D | — | — | |
| 10 | Common | Common Stock | 2023-01-26 | S | D | 400 | $320.25 | 2,555 | D | — | — | (F2) Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F10) Open market sales reported on this line occurred at a weighted average price of $320.25 (range $319.80 to $320.77). |
| 11 | Common | Common Stock | 2023-01-26 | S | D | 680 | $320.94 | 1,875 | D | — | — | (F11) Open market sales reported on this line occurred at a weighted average price of $320.94 (range $320.89 to $320.99). (F2) Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
| 12 | Derivative | Stock Option (Right to Buy) | 2023-01-26 | M | D | 4,000 | $0.00 | 1,429 | D | $72.14 · — to 2024-05-31 | 4,000 Common Stock | (F12) Fully vested. |
| 13 | Derivative | Stock Option (Right to Buy) | 2023-01-25 | M | D | 4,000 | $0.00 | 5,429 | D | $72.14 · — to 2024-05-31 | 4,000 Common Stock | (F12) Fully vested. |